Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
China Biologic Reports Financial Results for the Third Quarter of 2020 2020-11-25 05:30
OliPass Announces Formation of Scientific Advisory Board of Pioneers in Sodium Ion Channellopathy and Pain 2020-11-24 22:00
Novel Antioxidant Seen as an Effective Strategy for Peripheral Artery Disease 2020-11-20 23:07
CARsgen Therapeutics to Present Multiple Myeloma Cell Therapy Data at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition in December 2020-11-20 19:00
China Biologic Enters into Definitive Merger Agreement for Going Private Transaction 2020-11-19 21:09
VolitionRx Limited to Present COVID-19 Data at MEDICA 2020 2020-11-19 20:00
Samsung Biologics breaks ground on Super Plant, the world's largest and most innovative bio-manufacturing facility 2020-11-18 20:00
Samsung Biologics announces strategic manufacturing partnership with Lilly to accelerate delivery of COVID-19 antibody treatments 2020-11-17 20:00
Foresee Pharmaceuticals Enters Exclusive License Agreement with GenSci for the Commercialization of Camcevi(TM) in China 2020-11-17 17:51
CPhI & P-MEC China 2020 adapts to customer needs with hybrid pharma event 2020-11-17 15:00
Alterity announces approval of US patent for next generation compounds to treat neurodegenerative diseases 2020-11-16 21:42
Happiness Biotech Starts Offering Kingdomway Coenzyme Q10 in Its Experience Stores 2020-11-16 21:00
PharmAbcine to present the final data of Phase IIa rGBM trial at SNO 2020 2020-11-16 21:00
PTC Therapeutics Announces Initiation of Phase 2/3 Clinical Trial in Australia to Evaluate PTC299 for the Treatment of COVID-19 2020-11-16 05:00
Biortus Announces Round A Financing and Launches Global Cryo-EM Innovation Center 2020-11-14 12:40
China Pharma Holdings, Inc. Reports Third Quarter 2020 Financial Results 2020-11-14 05:10
China Biologic Products to Report Third Quarter 2020 Financial Results 2020-11-13 21:00
OrigiMed and Takeda Announced Partnership to Accelerate R&D and Commercialization of Innovative Medicines 2020-11-11 21:26
I-Mab Announces Preclinical Data on Differentiated Anti-C5aR Antibody TJ210/MOR210 at SITC 2020 2020-11-11 21:00
Asieris Announces First Patient Administration in the Global Phase III Clinical Trial for APL-1702 2020-11-11 17:08
1 113 114 115 116 117 165